Blockade of the hERG potassium channel proteins by specific agents can inhibit the proliferation and metastasis of tumor cells and the corresponding [15, 16], increasing the sensitivity of tumor cells to chemotherapeutic drugs. This evidence concerns the gene KCNH2 and neoplasm.